Atlas Trials

Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT02541643 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT02541643
Sponsor
Sundar Jagannath
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Multiple Myeloma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.